Legal & General Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $182M | Buy |
|
|||||
2025
Q1 | $176M | Buy |
|
|||||
2024
Q4 | $188M | Sell |
|
|||||
2024
Q3 | $243M | Sell |
|
|||||
2024
Q2 | $294M | Sell |
|
|||||
2024
Q1 | $282M | Sell |
|
|||||
2023
Q4 | $343M | Sell |
|
|||||
2023
Q3 | $344M | Sell |
|
|||||
2023
Q2 | $390M | Buy |
|
|||||
2023
Q1 | $378M | Sell |
|
|||||
2022
Q4 | $382M | Sell |
|
|||||
2022
Q3 | $382M | Sell |
|
|||||
2022
Q2 | $297M | Buy |
|
|||||
2022
Q1 | $303M | Buy |
|
|||||
2021
Q4 | $326M | Sell |
|
|||||
2021
Q3 | $398M | Buy |
|
|||||
2021
Q2 | $480M | Buy |
|
|||||
2021
Q1 | $335M | Sell |
|
|||||
2020
Q4 | $301M | Sell |
|
|||||
2020
Q3 | $362M | Sell |
|
|||||
2020
Q2 | $351M | Buy |
|
|||||
2020
Q1 | $399M | Buy |
|
|||||
2019
Q4 | $373M | Buy |
|
|||||
2019
Q3 | $289M | Buy |
|
|||||
2019
Q2 | $286M | Sell |
|
|||||
2019
Q1 | $291M | Buy |
|
|||||
2018
Q4 | $302M | Buy |
|
|||||
2018
Q3 | $336M | Sell |
|
|||||
2018
Q2 | $282M | Sell |
|
|||||
2018
Q1 | $280M | Sell |
|
|||||
2017
Q4 | $339M | Sell |
|
|||||
2017
Q3 | $341M | Buy |
|
|||||
2017
Q2 | $291M | Buy |
|
|||||
2017
Q1 | $286M | Buy |
|
|||||
2016
Q4 | $285M | Buy |
|
|||||
2016
Q3 | $312M | Buy |
|
|||||
2016
Q2 | $240M | Buy |
|
|||||
2016
Q1 | $253M | Buy |
|
|||||
2015
Q4 | $293M | Sell |
|
|||||
2015
Q3 | $287M | Buy |
|
|||||
2015
Q2 | $383M | Buy |
|
|||||
2015
Q1 | $396M | Sell |
|
|||||
2014
Q4 | $319M | Sell |
|
|||||
2014
Q3 | $321M | Sell |
|
|||||
2014
Q2 | $315M | Buy |
|
|||||
2014
Q1 | $304M | Sell |
|
|||||
2013
Q4 | $285M | Sell |
|
|||||
2013
Q3 | $246M | Sell |
|
|||||
2013
Q2 | $220M | Buy |
|